PFG Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$900K Buy
4,074
+192
+5% +$53.1K 0.05% 396
2026
Q1
$1.15M Buy
3,882
+197
+5% +$58.5K 0.06% 344
2025
Q4
$1.01M Buy
3,685
+2,787
+310% +$757K 0.05% 380
2025
Q3
$243K Buy
898
+94
+12% +$25.6K 0.01% 745
2025
Q2
$222K Buy
+804
New +$219K 0.01% 582
2020
Q3
Sell
-4,012
Closed -$660K 358
2020
Q2
$660K Sell
4,012
-3,484
-46% -$624K 0.15% 169
2020
Q1
$1.38M Sell
7,496
-88
-1% -$17.5K 0.37% 87
2019
Q4
$1.56M Buy
7,584
+14
+0.2% +$2.87K 0.38% 81
2019
Q3
$1.63M Buy
7,570
+260
+4% +$54.3K 0.45% 59
2019
Q2
$1.47M Buy
7,310
+65
+0.9% +$12K 0.4% 77
2019
Q1
$1.3M Sell
7,245
-155
-2% -$27.4K 0.39% 81
2018
Q4
$1.32M Buy
+7,400
New +$1.37M 0.42% 78

Other funds holding CME

PFG Advisors's CME Position: Q2 2026 in Review

PFG Advisors increased its CME Group (CME) stake by 4.9% in Q2 2026, buying an estimated $53.1K and bringing the position to 4,074 shares worth $900K. The position accounts for 0.05% of the portfolio, ranked #396.

PFG Advisors first reported a position in CME in Q4 2018 and has held it in 12 quarters since. The position peaked at $1.63M in Q3 2019. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • PFG Advisors held 4,074 shares of CME Group worth $900K as of Q2 2026.
  • PFG Advisors bought 192 CME Group shares in Q2 2026, an estimated $53.1K.
  • CME Group made up 0.05% of PFG Advisors's portfolio in Q2 2026, its #396 holding.
  • PFG Advisors first reported a position in CME Group in Q4 2018 and has held it in 12 quarters since.
  • PFG Advisors's CME Group position peaked at $1.63M in Q3 2019.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on PFG Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.